1. Home
  2. KOSS vs CGTX Comparison

KOSS vs CGTX Comparison

Compare KOSS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • CGTX
  • Stock Information
  • Founded
  • KOSS 1953
  • CGTX 2007
  • Country
  • KOSS United States
  • CGTX United States
  • Employees
  • KOSS N/A
  • CGTX N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOSS Consumer Staples
  • CGTX Health Care
  • Exchange
  • KOSS Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • KOSS 63.0M
  • CGTX 79.3M
  • IPO Year
  • KOSS N/A
  • CGTX 2021
  • Fundamental
  • Price
  • KOSS $7.34
  • CGTX $0.55
  • Analyst Decision
  • KOSS
  • CGTX Buy
  • Analyst Count
  • KOSS 0
  • CGTX 6
  • Target Price
  • KOSS N/A
  • CGTX $8.00
  • AVG Volume (30 Days)
  • KOSS 183.8K
  • CGTX 588.8K
  • Earning Date
  • KOSS 11-08-2024
  • CGTX 11-08-2024
  • Dividend Yield
  • KOSS N/A
  • CGTX N/A
  • EPS Growth
  • KOSS N/A
  • CGTX N/A
  • EPS
  • KOSS N/A
  • CGTX N/A
  • Revenue
  • KOSS $12,265,069.00
  • CGTX N/A
  • Revenue This Year
  • KOSS N/A
  • CGTX N/A
  • Revenue Next Year
  • KOSS N/A
  • CGTX N/A
  • P/E Ratio
  • KOSS N/A
  • CGTX N/A
  • Revenue Growth
  • KOSS N/A
  • CGTX N/A
  • 52 Week Low
  • KOSS $2.27
  • CGTX $0.34
  • 52 Week High
  • KOSS $18.73
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 50.17
  • CGTX 54.28
  • Support Level
  • KOSS $7.00
  • CGTX $0.50
  • Resistance Level
  • KOSS $7.83
  • CGTX $0.64
  • Average True Range (ATR)
  • KOSS 0.44
  • CGTX 0.07
  • MACD
  • KOSS -0.01
  • CGTX 0.02
  • Stochastic Oscillator
  • KOSS 32.26
  • CGTX 67.74

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: